Accelrys Posts 2 Percent Revenue Gain for Q2; Cuts 12 Percent of Staff

Aug 01, 2013

|

NEW YORK (GenomeWeb News) – Scientific informatics firm Accelrys reported after the close of the market Wednesday that its second-quarter revenues increased nearly 2 percent year over year, as it announced cost-cutting measures including the termination of 80 positions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Add the Missing Data

A federal judge has ruled that drug companies, device manufacturers, and universities need to provide missing clinical data from hundreds of trials to a federal website, ScienceInsider reports.

Two Red Panda Species

A genetic analysis suggests red pandas might actually belong to two different species, New Scientist reports.

Kit Fix

NPR reports that the US Centers for Disease Control and Prevention has fixed the problem with some of its SARS-CoV-2 testing kits.

Nature Papers Explore Epigenetic Factors in Aging, Gene Loss in Animal Kingdom

In Nature this week: epigenetic factors that prevent healthy aging and more.

Featured White Papers

A Machine-Learning Framework for Accurate Classification and Quantification of Oncogenic Variants Using the QuantideX NGS DNA Hotspot 21 Kit

Powering Precision Medicine at Apollo Genetics: A GenomeWeb eCase Study Transcript

Accelerating Genomic Discoveries for Precision Medicine

Advancing Genomics in the Age of Big Data with GPU Acceleration

Mar

18

Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar

31

Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

Menu

Accelrys Posts 2 Percent Revenue Gain for Q2; Cuts 12 Percent of Staff

To read the full story....

Breaking News

In Brief This Week: PerkinElmer, Stilla Technologies, Emedgene, and More

PerkinElmer SCID Test Chosen for Newborn Screening Evaluation in England

First Analysis Upgrades NeoGenomics to Strong Buy After Stock Dips

New Products Posted to GenomeWeb: TwinStrand Biosciences, Blueprint Genetics, S2 Genomics, More

Local Coverage Determinations Roundup: Natera, DermTech

DNA Methylation Mapping in Genetic Syndromes Leads to Disease-Specific Episignatures

The Scan

Add the Missing Data

Two Red Panda Species

Kit Fix

Nature Papers Explore Epigenetic Factors in Aging, Gene Loss in Animal Kingdom

Featured White Papers

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

What's Popular?

Sophia Genetics to Provide Interpretation Services to MGI Customers

10x Genomics Unveils 2020 New Product Pipeline at AGBT

Twist Bioscience, Sophia Genetics Team on Genomic Analysis

Epic EMR Users Begin Integrating Genomics Data for Clinical Decision Support

Startup Spesana Developing MDx Clinical Decision Support Software

Sponsorships